Comparing outcomes of ILD patients managed in specialised versus non-specialised centres

Respiratory Research

Table 4 IPTW-weighted logistic regression for change in pharmaceutical treatment patterns in the 3 months after confirmed diagnosis

	OR (95% CI)
Antifibrotics	2.43 (1.92, 3.03)*
Immunosuppressants	1.28 (1.01, 1.60)*
Acetylcysteine	1.21 (0.97, 1.48)
Glucocorticoids, corticosteroids	1.03 (0.97, 1.08)
Treatment with anti-clotting drugs	0.87 (0.79, 0.96)*
Treatment with anti-acid drugs	0.97 (0.93, 1.02)
Treatment with anti-depressants	0.92 (0.80, 1.05)
Treatment with anti-diabetic drugs	1.00 (0.90, 1.11)
Treatment with drugs against obstructive airway disease	0.86 (0.78, 0.93)*
Treatment of pulmonary hypertension	1.74 (1.24, 2.37)*
Treatment of heart insufficiency/cardiac arrhythmia	0.86 (0.80, 0.93)*
Treatment of cardiovascular disease	0.98 (0.94, 1.03)

IPTW-weighted logistic regression for probability of receiving the investigated pharmaceutical in the 3 months after the confirmed diagnosis. Propensity score model included information on drug prescriptions before the diagnosis
CI: Confidence interval, IPTW: Inverse probability of treatment weighting, OR: Odds ratio
^*Statistically significant results

ISSN: 1465-993X